These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

985 related items for PubMed ID: 23610862

  • 1. Association of interleukin-1 beta (+3954) gene polymorphism and gingival crevicular fluid levels in patients with aggressive and chronic periodontitis.
    Yücel OO, Berker E, Mescil L, Eratalay K, Tepe E, Tezcan I.
    Genet Couns; 2013; 24(1):21-35. PubMed ID: 23610862
    [Abstract] [Full Text] [Related]

  • 2. Analysis of TNF-α (-308) polymorphism and gingival crevicular fluid TNF-α levels in aggressive and chronic periodontitis: A preliminary report.
    Özer Yücel Ö, Berker E, Mesci L, Eratalay K, Tepe E, Tezcan İ.
    Cytokine; 2015 Apr; 72(2):173-7. PubMed ID: 25647273
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid.
    Engebretson SP, Lamster IB, Herrera-Abreu M, Celenti RS, Timms JM, Chaudhary AG, di Giovine FS, Kornman KS.
    J Periodontol; 1999 Jun; 70(6):567-73. PubMed ID: 10397510
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
    Toyman U, Tüter G, Kurtiş B, Kıvrak E, Bozkurt Ş, Yücel AA, Serdar M.
    J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
    Tüter G, Kurtiş B, Serdar M.
    J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MMP-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF MMP-13 levels and outcome of periodontal therapy.
    Pirhan D, Atilla G, Emingil G, Tervahartiala T, Sorsa T, Berdeli A.
    J Clin Periodontol; 2009 Jun; 36(6):474-81. PubMed ID: 19453573
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Soluble interleukin-1 receptor type II levels in gingival crevicular fluid in aggressive and chronic periodontitis.
    Suzuki M, Ishihara Y, Kamiya Y, Koide M, Fuma D, Fujita S, Matsumura Y, Suga T, Kamei H, Noguchi T.
    J Periodontol; 2008 Mar; 79(3):495-500. PubMed ID: 18315432
    [Abstract] [Full Text] [Related]

  • 18. Correlation of the interleukin-29 levels in crevicular fluid and plasma with the genetic polymorphism in chronic and aggressive periodontitis patients.
    Shivaprasad BM, Pradeep AR.
    Arch Oral Biol; 2015 Jan; 60(1):37-44. PubMed ID: 25255471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.